Physician profile
William E Betts
NPI 1639458409
$41,100.89
in general payments reported to CMS, 2019-2025
13 companies · $19.43 in 2025
The $19.43 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15K · 2022: $14K · 2023: $12K · 2024: $191 · 2025: $19.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,350 · Travel and Lodging: $1,681 · Food and Beverage: $1,066.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,350.00 |
| Travel and Lodging | $1,680.57 |
| Food and Beverage | $1,065.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $40,442.96 | 2021-2024 | |
| Teva Pharmaceuticals USA, INC. | $295.31 | 2021-2025 | Austedo Xr, Austedo, Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $63.57 | 2022-2023 | Abilify Maintena |
| Lundbeck LLC | $53.15 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $36.41 | 2022 | |
| Vanda Pharmaceuticals INC. | $35.73 | 2022 | |
| Alkermes, INC. | $34.42 | 2022-2023 | Lybalvi |
| Eisai INC. | $31.83 | 2022 | |
| Axsome Therapeutics, INC. | $26.70 | 2023 | Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $22.63 | 2022 | |
| Corium, LLC | $21.60 | 2022 | |
| Sunovion Pharmaceuticals INC. | $21.26 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Betts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.